SODIUM, MONOBASIC, ANHYDROUS: 73 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
73
Total FAERS Reports
29 (39.7%)
Deaths Reported
49
Hospitalizations
73
As Primary/Secondary Suspect
17
Life-Threatening
21
Disabilities
Active Ingredient: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS ·
First Report: 2012 · Latest Report: 20240905
What Are the Most Common SODIUM, MONOBASIC, ANHYDROUS Side Effects?
#1 Most Reported
Vomiting
21 reports (28.8%)
#2 Most Reported
Methaemoglobinaemia
20 reports (27.4%)
#3 Most Reported
Abdominal distension
20 reports (27.4%)
All SODIUM, MONOBASIC, ANHYDROUS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Vomiting | 21 | 28.8% | 18 | 15 |
| Abdominal distension | 20 | 27.4% | 20 | 14 |
| Methaemoglobinaemia | 20 | 27.4% | 0 | 20 |
| Stress | 17 | 23.3% | 17 | 11 |
| Abdominal pain | 16 | 21.9% | 16 | 10 |
| Appendicitis | 16 | 21.9% | 16 | 10 |
| Appendicolith | 16 | 21.9% | 16 | 10 |
| Ascites | 16 | 21.9% | 16 | 10 |
| Hyponatraemia | 16 | 21.9% | 16 | 10 |
| Cardiogenic shock | 15 | 20.6% | 15 | 9 |
| Constipation | 15 | 20.6% | 15 | 9 |
| General physical health deterioration | 15 | 20.6% | 15 | 9 |
| Multiple organ dysfunction syndrome | 15 | 20.6% | 15 | 9 |
| Nausea | 15 | 20.6% | 15 | 9 |
| Off label use | 15 | 20.6% | 15 | 10 |
| Sepsis | 14 | 19.2% | 14 | 8 |
| Ventricular fibrillation | 14 | 19.2% | 14 | 10 |
| Blood phosphorus increased | 13 | 17.8% | 13 | 10 |
| Blood uric acid increased | 13 | 17.8% | 13 | 12 |
| Condition aggravated | 13 | 17.8% | 13 | 10 |
Who Reports SODIUM, MONOBASIC, ANHYDROUS Side Effects? Age & Gender Data
Gender: 15.0% female, 85.0% male. Average age: 70.6 years. Most reports from: CA. View detailed demographics →
Is SODIUM, MONOBASIC, ANHYDROUS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 1 | 0 | 0 |
| 2013 | 5 | 0 | 0 |
| 2014 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 0 |
| 2020 | 6 | 5 | 2 |
| 2022 | 5 | 1 | 4 |
| 2023 | 20 | 0 | 20 |
| 2024 | 2 | 0 | 2 |
What Is SODIUM, MONOBASIC, ANHYDROUS Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 27 |
| Constipation | 21 |
| Hypophosphataemia | 6 |
Official FDA Label for SODIUM, MONOBASIC, ANHYDROUS
Official prescribing information from the FDA-approved drug label.